Every year, 250,000 women globally are diagnosed with invasive ovarian cancer and 140,000 women die of the disease. This includes cancer of the ovaries, peritoneum, and/or Fallopian tube(s). Unlike many other forms of cancer, ovarian cancer is typically diagnosed at an advanced stage and requires treatment with aggressive surgery and multiple rounds of combination chemotherapy. Although most patients typically respond to upfront treatment, the most aggressive forms of this cancer are often deadly.
The purpose of The Ovarian Cancer Registry is to recruit all women with a history of ovarian, peritoneal or tubal cancer to join a movement and call to action to make contributions to advance ovarian cancer research.
Our research will work to improve quality of life, symptom management, patient experience and clinical outcomes. Another set of goals is to reduce cancer health disparities and barriers to care. In addition, we want to put a spotlight on the issues and concerns that matter to ovarian cancer patients. We hope that this type of patient-centered research will lead to improvements in healthcare policy, more effective standards of care and better outcomes for patients.
CALL TO ACTION
Together we can make the difference! The more people who join and contribute, the greater impact we may have.
- If you are a patient or survivor with invasive ovarian, peritoneal or tubal cancer, please Join the Registry today.
- If your loved one has invasive ovarian, peritoneal or tubal cancer, please share information about the Registry and encourage them to Learn More and Join the Registry.